ERα prevents tumorigenesis of both liver and breast cancer cells through CCN5
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.06.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Daoshan Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, No. 1 Xuefu North R…. Hauptthemen laut MEDLINE: Breast Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NCI NIH HHS, University of Western Australia, National Computational Infrastructure.
Abstract (Originalsprache)
Estrogen receptor alpha (ERα)-mediated estrogen signaling has also shown to prevent hepatic tumorigenesis in mice. Consistent with this, hormone replacement therapy with estrogen supplementation dramatically reduced the risk of hepatocellular carcinoma. Silencing of ERα is also a key event for the transformation of ERα-positive breast cancer cells into malignant triple-negative breast cancer cells. However, the mechanisms underlying ERα-mediated prevention of both hepatic and mammary tumorigenesis in humans are still unclear. Here, we present a functional genomics study of ERα targeting by comparing human liver cancer cells with human breast cancer cells using "loss or gain of function" genetic assays of ERα in vitro and in vivo. We discover that cellular communication network factor 5 (CCN5) is a direct downstream target of ERα; ERα suppresses growth and prevents tumorigenesis and malignant transformation of both liver and breast cancer cells through CCN5 in humans. The ERα-CCN5 regulatory axis functions as suppressors for both hepatic and mammary tumors, which is a common mechanism of preventing tumorigenesis for both liver cancer and breast cancer in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, No. 1 Xuefu North Road, University Town, Fuzhou, Fujian Province, 350112, China.
- School of Biomedical Sciences, University of Western Australia, QE II, M Block 225C, Crawley, WA, 6009, Australia.
- School of Biomedical Sciences, University of Western Australia, QE II, M Block 225C, Crawley, WA, 6009, Australia. Electronic address: zhaoyu.li@uwa.edu.au.
Förderung
- NCI NIH HHS
- University of Western Australia
- National Computational Infrastructure
Zitieren
APA
Zheng, D., Bashir, M., & Li, Z. (2023). ERα prevents tumorigenesis of both liver and breast cancer cells through CCN5. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.06.018
Vancouver
Zheng D, Bashir M, Li Z. ERα prevents tumorigenesis of both liver and breast cancer cells through CCN5. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.06.018
BibTeX
@article{Zheng2023,
author = {Zheng, Daoshan and Bashir, Muniba and Li, Zhaoyu},
title = {ERα prevents tumorigenesis of both liver and breast cancer cells through CCN5},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.06.018}
}
EUVIMED